Semaglutide vs Tirzepatide: Dose Equivalence Chart
Both are GLP-1 family peptides but they are not milligram-for-milligram equivalent. Tirzepatide also activates the GIP receptor, so its weight-loss effect per mg is greater. This chart estimates clinical equivalence from the head-to-head SURMOUNT-5 data and related studies.
Equivalence chart
| Semaglutide | Approximate tirzepatide equivalent |
|---|---|
| 0.25 mg | 2.5 mg |
| 0.5 mg | 2.5 mg |
| 1.0 mg | 5 mg |
| 1.7 mg | 7.5 mg |
| 2.4 mg | 10 mg |
Switching between the two
If switching from semaglutide to tirzepatide, drop one notch on the equivalence chart for the first 4 weeks to avoid GI side effects from the GIP component. From tirzepatide to semaglutide, start at the equivalent dose — semaglutide is the gentler of the two on GI tolerance.
Why equivalence matters
Many UK buyers transition between the two as supply or budget dictates. A clean equivalence prevents lost weeks of titration. For other comparisons, see retatrutide vs tirzepatide.
Frequently asked questions
Is tirzepatide twice as strong as semaglutide?
Roughly 2x at low doses and 4–5x at high doses, because of the GIP synergy.
Can I just multiply by 5?
Only loosely. The chart is more accurate than a single multiplier.
Does this apply to retatrutide?
No — see our dedicated retatrutide vs tirzepatide guide.
This guide is provided for informational purposes by Next Day Pharma. All peptides supplied are FOR RECONSTITUTION. Always consult a qualified healthcare professional before use.